EP3081097B8 - Composition for the treatment of infertility - Google Patents

Composition for the treatment of infertility Download PDF

Info

Publication number
EP3081097B8
EP3081097B8 EP16171147.8A EP16171147A EP3081097B8 EP 3081097 B8 EP3081097 B8 EP 3081097B8 EP 16171147 A EP16171147 A EP 16171147A EP 3081097 B8 EP3081097 B8 EP 3081097B8
Authority
EP
European Patent Office
Prior art keywords
infertility
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP16171147.8A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3081097B1 (en
EP3081097A1 (en
Inventor
Luigi Amelotti
Lorenzo Secondini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Uriach Italy SRL
Original Assignee
Uriach Italy SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43736968&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP3081097(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Uriach Italy SRL filed Critical Uriach Italy SRL
Priority to PL16171147T priority Critical patent/PL3081097T3/pl
Publication of EP3081097A1 publication Critical patent/EP3081097A1/en
Publication of EP3081097B1 publication Critical patent/EP3081097B1/en
Application granted granted Critical
Publication of EP3081097B8 publication Critical patent/EP3081097B8/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP16171147.8A 2010-12-17 2011-12-19 Composition for the treatment of infertility Active EP3081097B8 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL16171147T PL3081097T3 (pl) 2010-12-17 2011-12-19 Kompozycja do leczenia bezpłodności

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2010A002313A IT1403587B1 (it) 2010-12-17 2010-12-17 Composizione per il trattamento di disordini metabolici
EP11813358.6A EP2651251B1 (en) 2010-12-17 2011-12-19 Composition for the treatment of infertility
PCT/IB2011/003085 WO2012080831A1 (en) 2010-12-17 2011-12-19 Composition for the treatment of metabolic disorders

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
EP11813358.6A Division EP2651251B1 (en) 2010-12-17 2011-12-19 Composition for the treatment of infertility

Publications (3)

Publication Number Publication Date
EP3081097A1 EP3081097A1 (en) 2016-10-19
EP3081097B1 EP3081097B1 (en) 2019-12-04
EP3081097B8 true EP3081097B8 (en) 2020-01-08

Family

ID=43736968

Family Applications (2)

Application Number Title Priority Date Filing Date
EP11813358.6A Active EP2651251B1 (en) 2010-12-17 2011-12-19 Composition for the treatment of infertility
EP16171147.8A Active EP3081097B8 (en) 2010-12-17 2011-12-19 Composition for the treatment of infertility

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP11813358.6A Active EP2651251B1 (en) 2010-12-17 2011-12-19 Composition for the treatment of infertility

Country Status (12)

Country Link
EP (2) EP2651251B1 (ru)
BR (1) BR112013015048A2 (ru)
DK (2) DK2651251T3 (ru)
ES (2) ES2763437T3 (ru)
HR (1) HRP20160978T1 (ru)
HU (2) HUE047320T2 (ru)
IT (1) IT1403587B1 (ru)
PL (2) PL3081097T3 (ru)
PT (2) PT2651251T (ru)
RS (1) RS55057B1 (ru)
RU (1) RU2586742C2 (ru)
WO (1) WO2012080831A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011088333A2 (en) 2010-01-14 2011-07-21 Zars Pharma, Inc. Solid-forming local anesthetic formulations for pain control
ITMI20130349A1 (it) * 2013-03-07 2014-09-08 Laborest Italia S P A Composizione per uso nel trattamento della sindrome dell ovaio policistico
ITUA20163025A1 (it) 2016-04-29 2017-10-29 Sochim Int S P A Composizione per il trattamento della sindrome dell’ovaio policistico
US11898184B2 (en) 2017-09-07 2024-02-13 Sweet Sense Inc. Low glycemic sugar composition
EP3886814A1 (en) 2018-11-26 2021-10-06 The Procter & Gamble Company Solid pharmaceutical preparation containing lipoic acid and use thereof
RU2757220C1 (ru) * 2020-06-03 2021-10-12 Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" Фармацевтическая композиция для профилактики и лечения синдрома поликистозных яичников

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2152787C2 (ru) * 1994-06-02 2000-07-20 Дан Рига Лекарство против стресса, против снижения уровня активности и против старения и способ его получения
US20020155163A1 (en) * 1999-12-27 2002-10-24 Samuel D. Benjamin Integrated multi-vitamin and mineral combination
US20040043013A1 (en) * 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
US20070065456A1 (en) * 2005-09-20 2007-03-22 Woods Cindy J Nutritional supplements

Also Published As

Publication number Publication date
BR112013015048A2 (pt) 2016-07-19
DK2651251T3 (en) 2016-09-05
ES2586930T3 (es) 2016-10-19
RU2013130308A (ru) 2015-01-27
PT2651251T (pt) 2016-08-19
HRP20160978T1 (hr) 2016-10-07
EP3081097B1 (en) 2019-12-04
DK3081097T3 (da) 2020-01-20
HUE029493T2 (en) 2017-02-28
EP2651251A1 (en) 2013-10-23
EP2651251B1 (en) 2016-06-01
PL3081097T3 (pl) 2020-06-15
ES2763437T3 (es) 2020-05-28
IT1403587B1 (it) 2013-10-31
ITMI20102313A1 (it) 2012-06-18
RS55057B1 (sr) 2016-12-30
PL2651251T3 (pl) 2017-06-30
HUE047320T2 (hu) 2020-04-28
EP3081097A1 (en) 2016-10-19
PT3081097T (pt) 2020-01-14
WO2012080831A1 (en) 2012-06-21
RU2586742C2 (ru) 2016-06-10

Similar Documents

Publication Publication Date Title
EP2554175A4 (en) COMPOSITION FOR THE TREATMENT OF A DESIRED PART
EP2552874A4 (en) PROCESS FOR PREPARING HEXAFLUOR-2 BUTENE
EP2654745A4 (en) COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN
EP2526993A4 (en) Treatment tool
EP2558432A4 (en) METHOD FOR THE PRODUCTION OF TETRAFLUOROLEFINES
SG2014014724A (en) METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
SI2605764T1 (sl) Sestavki za zdravljenje raka
EP3081097B8 (en) Composition for the treatment of infertility
WO2011153429A9 (en) Methods of treatment
IL221184A (en) A process for preparing 1-alkylated tetrazole 5 is produced
WO2011088020A9 (en) Modified saponins for the treatment of fungal infections
EP2596007A4 (en) PROCESS FOR THE PREPARATION OF 17-DEOXY-CORTICOSTEROIDS
AU2011290175A8 (en) Composition for improving skin quality
PT2460509T (pt) Composição para tratamento de verrugas
ZA201300546B (en) Process for the preparation of 3-haloalkylpyrazoles
PT2593423E (pt) Processo para a preparação de agentes de contraste
PT2390246T (pt) Processo para a preparação de aminaftona
PT2598504E (pt) Novo processo de fabrico de dimiracetam
AU2010901718A0 (en) Eczema treatment
AU2010901680A0 (en) Treatment of metals
AU2010902823A0 (en) Compound for the treatment of enteroviruses
IL224304A (en) A process for making dichlorobulben
AU2010901837A0 (en) Methods of treatment
AU2010904886A0 (en) Composition
AU2010901838A0 (en) Composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160524

AC Divisional application: reference to earlier application

Ref document number: 2651251

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20170816

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 3/04 20060101ALI20190527BHEP

Ipc: A23L 33/15 20160101AFI20190527BHEP

Ipc: A61K 31/047 20060101ALI20190527BHEP

Ipc: A61P 3/08 20060101ALI20190527BHEP

Ipc: A61K 31/6615 20060101ALI20190527BHEP

Ipc: A61K 31/519 20060101ALI20190527BHEP

Ipc: A61P 5/24 20060101ALI20190527BHEP

Ipc: A61K 31/714 20060101ALI20190527BHEP

Ipc: A61K 31/4415 20060101ALI20190527BHEP

Ipc: A61P 1/18 20060101ALI20190527BHEP

Ipc: A61P 1/16 20060101ALI20190527BHEP

Ipc: A61K 31/385 20060101ALI20190527BHEP

Ipc: A23L 33/00 20160101ALI20190527BHEP

Ipc: A23L 33/12 20160101ALI20190527BHEP

Ipc: A61P 3/06 20060101ALI20190527BHEP

Ipc: A61P 9/10 20060101ALI20190527BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20190705

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AC Divisional application: reference to earlier application

Ref document number: 2651251

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: CH

Ref legal event code: PK

Free format text: BERICHTIGUNG B8

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1208274

Country of ref document: AT

Kind code of ref document: T

Effective date: 20191215

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602011063881

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: RO

Ref legal event code: EPE

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: URIACH ITALY S.R.L.

REG Reference to a national code

Ref country code: FI

Ref legal event code: FGE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 602011063881

Country of ref document: DE

Owner name: URIACH ITALY S.R.L., ASSAGO, IT

Free format text: FORMER OWNER: URIACH ITALY S.R.L., ASSAGO, MI, IT

Ref country code: DE

Ref legal event code: R081

Ref document number: 602011063881

Country of ref document: DE

Owner name: URIACH ITALY S.R.L., ASSAGO, IT

Free format text: FORMER OWNER: LABOREST ITALIA S.R.L., NERVIANO, IT

Ref country code: DE

Ref legal event code: R082

Ref document number: 602011063881

Country of ref document: DE

Representative=s name: HOFFMANN - EITLE PATENT- UND RECHTSANWAELTE PA, DE

REG Reference to a national code

Ref country code: PT

Ref legal event code: SC4A

Ref document number: 3081097

Country of ref document: PT

Date of ref document: 20200114

Kind code of ref document: T

Free format text: AVAILABILITY OF NATIONAL TRANSLATION

Effective date: 20191226

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20200113

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: NO

Ref legal event code: T2

Effective date: 20191204

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: VALIPAT S.A. C/O BOVARD SA NEUCHATEL, CH

REG Reference to a national code

Ref country code: GR

Ref legal event code: EP

Ref document number: 20190404006

Country of ref document: GR

Effective date: 20200318

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: HU

Ref legal event code: AG4A

Ref document number: E047320

Country of ref document: HU

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191204

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191204

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2763437

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20200528

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191204

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191204

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191204

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191204

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200404

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191204

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602011063881

Country of ref document: DE

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1208274

Country of ref document: AT

Kind code of ref document: T

Effective date: 20191204

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191204

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20191219

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20191219

26N No opposition filed

Effective date: 20200907

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191204

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191204

REG Reference to a national code

Ref country code: SE

Ref legal event code: RPOT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191204

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191204

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 602011063881

Country of ref document: DE

Representative=s name: FRANKE & PARTNER PATENT- UND RECHTSANWAELTE IN, DE

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230607

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 20231215

Year of fee payment: 13

Ref country code: GB

Payment date: 20231215

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SM

Payment date: 20231218

Year of fee payment: 13

Ref country code: SE

Payment date: 20231214

Year of fee payment: 13

Ref country code: RO

Payment date: 20231218

Year of fee payment: 13

Ref country code: PT

Payment date: 20231213

Year of fee payment: 13

Ref country code: NO

Payment date: 20231220

Year of fee payment: 13

Ref country code: NL

Payment date: 20231219

Year of fee payment: 13

Ref country code: MT

Payment date: 20231214

Year of fee payment: 13

Ref country code: IT

Payment date: 20231218

Year of fee payment: 13

Ref country code: HU

Payment date: 20231215

Year of fee payment: 13

Ref country code: FR

Payment date: 20231220

Year of fee payment: 13

Ref country code: FI

Payment date: 20231218

Year of fee payment: 13

Ref country code: DK

Payment date: 20231214

Year of fee payment: 13

Ref country code: CZ

Payment date: 20231214

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PL

Payment date: 20231214

Year of fee payment: 13

Ref country code: BE

Payment date: 20231220

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20240111

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20231218

Year of fee payment: 13

Ref country code: CH

Payment date: 20240101

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20231214

Year of fee payment: 13